Canadian Sec - Delayed Quote • CAD Sona Nanotech Inc. (SONA.CN) Follow Add holdings 0.3250 +0.0150 +(4.84%) At close: 3:39:48 PM EDT Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for SONA.CN 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: SONA.CN View More All News Press Releases SEC Filings BioVaxys and Sona Nanotech Enter Research Collaboration Sona Nanotech Announces Annual Options Grants Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model Q1 Virtual Investor Summit: On-Demand Presentations Now Live Sona Nanotech Inc. CEO David Regan to Present at the Investor Summit Virtual on March 11 Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update Sona Nanotech Issued Patent and Appoints New Board Member Sona Nanotech Grants Options